Stock News

United American Securities Position in Bank Of America Co (BAC) Has Cut by $5.82 Million; Barry Investment Advisors Lowered Its Teva Pharmaceutical Inds LTD (TEVA) Holding as Share Price Declined

Barry Investment Advisors Llc decreased its stake in Teva Pharmaceutical Inds Ltd (TEVA) by 44.38% based on its latest 2017Q3 regulatory filing with the SEC. Barry Investment Advisors Llc sold 56,063 shares as the company’s stock declined 15.11% while stock markets rallied. The institutional investor held 70,274 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $1.24 million, down from 126,337 at the end of the previous reported quarter. Barry Investment Advisors Llc who had been investing in Teva Pharmaceutical Inds Ltd for a number of months, seems to be less bullish one the $21.29B market cap company. The stock decreased 0.33% or $0.07 during the last trading session, reaching $20.95. About 9.87M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 41.70% since January 23, 2017 and is downtrending. It has underperformed by 58.40% the S&P500.

United American Securities Inc decreased its stake in Bank Of America Corporation Co (BAC) by 91.93% based on its latest 2017Q3 regulatory filing with the SEC. United American Securities Inc sold 232,880 shares as the company’s stock declined 6.00% while stock markets rallied. The institutional investor held 20,450 shares of the major banks company at the end of 2017Q3, valued at $518,000, down from 253,330 at the end of the previous reported quarter. United American Securities Inc who had been investing in Bank Of America Corporation Co for a number of months, seems to be less bullish one the $328.37B market cap company. The stock decreased 0.06% or $0.02 during the last trading session, reaching $31.92. About 56.09M shares traded. Bank of America Corporation (NYSE:BAC) has risen 58.64% since January 23, 2017 and is uptrending. It has outperformed by 41.94% the S&P500.

Among 33 analysts covering Teva Pharma (NYSE:TEVA), 8 have Buy rating, 7 Sell and 18 Hold. Therefore 24% are positive. Teva Pharma had 129 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Buy” rating by Citigroup given on Thursday, January 4. The rating was downgraded by RBC Capital Markets on Friday, August 4 to “Underperform”. The stock of Teva Pharmaceutical Industries Limited (NYSE:TEVA) has “Sell” rating given on Tuesday, September 5 by Credit Suisse. Mizuho downgraded the shares of TEVA in report on Monday, October 24 to “Neutral” rating. The company was maintained on Friday, July 14 by Piper Jaffray. The firm earned “Hold” rating on Friday, December 15 by Morgan Stanley. On Thursday, August 3 the stock rating was downgraded by Oppenheimer to “Perform”. As per Friday, August 4, the company rating was maintained by Maxim Group. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Wednesday, November 16. The firm has “Outperform” rating given on Thursday, July 14 by Oppenheimer.

Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on February, 12. They expect $0.75 EPS, down 44.85% or $0.61 from last year’s $1.36 per share. TEVA’s profit will be $761.99M for 6.98 P/E if the $0.75 EPS becomes a reality. After $0.95 actual EPS reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -21.05% negative EPS growth.

Since August 10, 2017, it had 0 insider purchases, and 1 sale for $2.10 million activity.

Among 32 analysts covering Bank of America (NYSE:BAC), 21 have Buy rating, 0 Sell and 11 Hold. Therefore 66% are positive. Bank of America had 105 analyst reports since July 21, 2015 according to SRatingsIntel. The firm has “Overweight” rating given on Wednesday, December 21 by Atlantic Securities. The rating was maintained by JP Morgan on Thursday, April 7 with “Overweight”. Macquarie Research upgraded the stock to “Outperform” rating in Thursday, February 16 report. RBC Capital Markets maintained the shares of BAC in report on Wednesday, June 14 with “Buy” rating. Oppenheimer maintained the stock with “Outperform” rating in Saturday, September 5 report. The stock has “Buy” rating by Deutsche Bank on Tuesday, August 25. The firm has “Hold” rating by BMO Capital Markets given on Wednesday, August 23. The rating was downgraded by Berenberg to “Hold” on Monday, April 24. The company was downgraded on Tuesday, September 13 by Societe Generale. The stock has “Buy” rating by Credit Suisse on Thursday, June 1.

Investors sentiment decreased to 1.04 in Q3 2017. Its down 0.08, from 1.12 in 2017Q2. It turned negative, as 68 investors sold BAC shares while 569 reduced holdings. 117 funds opened positions while 547 raised stakes. 6.91 billion shares or 9.01% more from 6.34 billion shares in 2017Q2 were reported. Jane Street Gp Ltd Liability accumulated 1.89 million shares. Menlo Advisors Ltd Com reported 4.66% in Bank of America Corporation (NYSE:BAC). Balyasny Asset Mgmt Ltd Liability Company reported 0.53% of its portfolio in Bank of America Corporation (NYSE:BAC). 2.63 million are held by Arizona State Retirement. Convergence Investment Limited Liability Com holds 1.16% of its portfolio in Bank of America Corporation (NYSE:BAC) for 321,762 shares. Trillium Asset Mngmt reported 1.25% stake. Kames Capital Public Limited Company stated it has 2.31 million shares or 1.6% of all its holdings. Freestone Capital Hldg Limited Liability Company holds 0.14% or 76,229 shares. 99,372 were accumulated by Tnb. Sei accumulated 0.68% or 7.18 million shares. Millennium Mgmt Llc holds 0.5% of its portfolio in Bank of America Corporation (NYSE:BAC) for 12.84 million shares. Advisor Prtn Limited Liability Corporation owns 203,882 shares for 1.01% of their portfolio. Bryn Mawr Com reported 0.08% of its portfolio in Bank of America Corporation (NYSE:BAC). Palisade Llc Nj owns 0.02% invested in Bank of America Corporation (NYSE:BAC) for 22,100 shares. Seatown Pte Limited stated it has 419,000 shares or 0.77% of all its holdings.

United American Securities Inc, which manages about $201.06 million and $205.64 million US Long portfolio, upped its stake in Facebook Inc Cl A (NASDAQ:FB) by 12,220 shares to 75,260 shares, valued at $12.86M in 2017Q3, according to the filing. It also increased its holding in Citigroup Inc Com New Isin#Us1 (NYSE:C) by 59,160 shares in the quarter, for a total of 68,250 shares, and has risen its stake in Southwest Airls Co Com (NYSE:LUV).

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Leave a Reply

Your email address will not be published. Required fields are marked *